Literature DB >> 3916082

Human tumour-associated antigens: targets for monoclonal antibody-mediated cancer therapy.

R A Reisfeld, D A Cheresh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3916082

Source DB:  PubMed          Journal:  Cancer Surv        ISSN： 0261-2429


× No keyword cloud information.
  4 in total

1.  Tenascin is a stromal marker for epithelial malignancy in the mammary gland.

Authors:  E J Mackie; R Chiquet-Ehrismann; C A Pearson; Y Inaguma; K Taya; Y Kawarada; T Sakakura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody.

Authors:  J J Starling; R S Maciak; N A Hinson; C L Nichols; S L Briggs; B C Laguzza
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Modulation of melanoma-associated antigens by monoclonal antibodies as visualized by radioimmunoelectron microscopy and radioantibody binding assay.

Authors:  W Tilgen; S Matzku; I Kaufmann; M Engstner; J Brüggen; W Dippold; D Petzoldt
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

4.  In vivo antitumor activity demonstrated with squamous carcinoma reactive monoclonal antibody-Vinca immunoconjugates.

Authors:  D A Johnson; J L Zimmermann; B C Laguzza; J N Eble
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.